Posts of - 2010

Biosimilar drug effective in addressing arthritic conditions to make significant entry into the $6.5 billion Enbrel market

Biosimilar drug effective in addressing arthritic conditions to make significant entry into the $6.5 billion Enbrel market

Biosimilar drug effective in addressing arthritic conditions to make significant entry into the $6.5 billion Enbrel market.. View…

ByByadminSep 3, 2010
AVESTHAGEN obtains India patent for AVENT™

AVESTHAGEN obtains India patent for AVENT™

AVESTHAGEN obtains India patent for AVENT™ .. View More

ByByadminSep 2, 2010
AVESTHAGEN moves towards Clinicals of its biosimilar AVENT™

AVESTHAGEN moves towards Clinicals of its biosimilar AVENT™

AVESTHAGEN moves towards Clinicals of its biosimilar AVENT™ .. View More

ByByadminJun 6, 2010
Women are writing the entrepreneurship code in biotech

Women are writing the entrepreneurship code in biotech

 Women are writing the entrepreneurship code in biotech.. View More

ByByadminJun 3, 2010
Image Not Found
error: